Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 22, 16:00
1351.45
-4.15 (-0.31%)
VOLUME 7,869
LIVE
NSE
Feb 22, 15:57
1350.30
-6.15 (-0.45%)
VOLUME 156,521
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Dec '17 Sep '17 Jun '17 Mar '17 Dec '16
Net Sales/Income from operations 500.78 469.14 397.93 397.81 490.51
Other Operating Income -- -- -- 20.69 18.09
Total Income From Operations 500.78 469.14 397.93 418.50 508.60
EXPENDITURE
Consumption of Raw Materials 87.27 81.14 93.80 79.14 96.93
Purchase of Traded Goods 26.34 14.64 18.59 15.55 18.10
Increase/Decrease in Stocks 4.95 10.84 -32.39 -5.99 12.79
Power & Fuel -- -- -- -- --
Employees Cost 84.20 82.15 79.78 69.09 69.28
Depreciation 14.34 13.95 12.93 18.87 14.73
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 144.44 122.93 128.08 118.82 136.00
P/L Before Other Inc. , Int., Excpt. Items & Tax 139.24 143.49 97.14 123.02 160.77
Other Income 64.69 7.93 4.70 7.36 51.08
P/L Before Int., Excpt. Items & Tax 203.93 151.42 101.84 130.38 211.85
Interest 0.10 0.05 0.04 0.74 0.59
P/L Before Exceptional Items & Tax 203.83 151.37 101.80 129.64 211.26
Exceptional Items -- -- -- -- --
P/L Before Tax 203.83 151.37 101.80 129.64 211.26
Tax 39.24 43.67 25.07 21.67 40.28
P/L After Tax from Ordinary Activities 164.59 107.70 76.73 107.97 170.98
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 1.65 107.70 76.73 107.97 170.98
Equity Share Capital 17.69 17.69 17.69 17.69 17.69
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 18.70 12.24 8.72 12.27 19.42
Diluted EPS 18.70 12.23 8.72 12.27 19.42
EPS After Extra Ordinary
Basic EPS 18.70 12.24 8.72 12.27 19.42
Diluted EPS 18.70 12.23 8.72 12.27 19.42
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.